Technology

Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disease.

Home October 30, 2008
Home
News

October 31, 2008 - Surface modification and drug delivery technologies company SurModics Inc. said today it is providing ...

Home October 30, 2008
Home
29432_1
Feature | Nick Obradovich

"Potential” can be a loaded word, especially in healthcare. Many clinicians have tagged coronary MR angiography (MRA) with the “potential” label. Despite the scan’s reported safety advantages over coronary CT angiography (CTA), as well as its superior physiologic information, coronary MRA has not gained the widespread acceptance of coronary CTA.

Home October 30, 2008
Home
Technology

The nSPEED reconstruction software from Digirad Corp. is for use in its imaging systems for SPECT procedures at either half-time and/or half count densities with parallel and nonparallel hole collimators, reportedly resulting in quicker exams, improved image quality and less radiation exposure.

Home October 30, 2008
Home
Technology

Stereotaxis Inc. said the FDA cleared its magnetically tipped PowerAssert radiofrequency (RF) guide wire to cross chronic total occlusions (CTOs) in the peripheral vasculature.

Home October 30, 2008
Home
Technology

Boston Scientific's TAXUS Express2 Atom paclitaxel-eluting coronary stent system is a drug-eluting stent (DES) specifically designed for treating small coronary vessels. The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, Boston Scientific said. The Taxus Express 2 Atom received FDA approval in the fall of 2008.

Home October 30, 2008
Home
News

October 31, 2008 - Corgenix Medical Corp. recently said new CHARISMA trial findings published in Circulation confirm ...

Home October 30, 2008
Home
29435_2
Feature | Maureen Leahy-Patano

Cardiovascular care does not occur in a single hospital setting; more often than not patients undergo a variety of tests at different locations. In order to provide the best care possible, physicians need immediate access to all patient information, no matter where, when or how it was obtained.

Home October 30, 2008
Home
News

October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting ...

Home October 29, 2008
Home
29425_4
Feature | Dave Fornell

There have been numerous new products released in the past year to enhance implantable pacing and defibrillation devices, but new advances in remote monitoring seem to be paving the way of the future.

Home October 29, 2008
Home
News

October 30, 2008 - CHF Solutions said seven studies supporting ultrafiltration therapy’s effectiveness and benefits in ...

Home October 29, 2008
Home
News

October 30, 2008 - Thinking Systems is debuting at RSNA 2008 its new release of the company’s unified Web-based ThinkingPACS/ThinkingRIS with comprehensive solutions for radiology, cardiology and molecular imaging.

Home October 29, 2008
Home
News

October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.

Home October 29, 2008
Home
News

October 30, 2008 - Thoratec Corp. this week notified healthcare professionals of a worldwide correction of the HeartMate ...

Home October 29, 2008
Home
29423_1
Feature | Dave Fornell

There is skepticism among cardiologists whether flat panel detectors can help lower the X-ray dose more than using traditional image intensifiers in the cath lab. There was a story concerning this in the last issue of DAIC which said flat panel detectors are replacing image intensifiers partly because they help lower the X-ray exposure to patients.

Home October 29, 2008
Home
Subscribe Now